Urbanucci, Alfonso
Barfeld, Stefan J.
Kytölä, Ville
Itkonen, Harri M.
Coleman, Ilsa M.
Vodák, Daniel
Sjöblom, Liisa
Sheng, Xia
Tolonen, Teemu
Minner, Sarah
Burdelski, Christoph
Kivinummi, Kati K.
Kohvakka, Annika
Kregel, Steven
Takhar, Mandeep
Alshalalfa, Mohammed
Davicioni, Elai
Erho, Nicholas
Lloyd, Paul
Karnes, R. Jeffrey
Ross, Ashley E.
Schaeffer, Edward M.
Vander Griend, Donald J.
Knapp, Stefan
Corey, Eva
Feng, Felix Y.
Nelson, Peter S.
Saatcioglu, Fahri
Knudsen, Karen E.
Tammela, Teuvo L.J.
Sauter, Guido
Schlomm, Thorsten
Nykter, Matti
Visakorpi, Tapio
Mills, Ian G.
Funding for this research was provided by:
South-East Norway Health Authorities (2014040)
MLS (390000, 143295)
Helse Sor-Ost (2014040)
Norwegian Research Council (230559)
Faculty of Medicine at the Oslo University Hospital
NIH (P50CA097186, P01CA163227)
Prostate Cancer Foundation
Norwegian Cancer Society (711072, 102032, 4521627)
SGC (1097737)
AbbVie
Bayer Pharma AG
Boehringer Ingelheim
Canada Foundation for Innovation
Eshelman Institute for Innovation
Genome Canada
Innovative Medicines Initiative (EU/EFPIA)
Janssen
Merck & Co.
Novartis Pharma AG
Ontario Ministry of Economic Development and Innovation
Pfizer
São Paulo Research Foundation-FAPESP
Takeda
Wellcome Trust
This article is maintained by: Elsevier
Article Title: Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer
Journal Title: Cell Reports
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.celrep.2017.05.049
Content Type: article
Copyright: © 2017 The Author(s).